设计,合成和优化TARO抑制剂作为多功能抗生素对抗抗甲素耐药黄金葡萄球菌
Yuanchen Zhong1,2, Feifei Chen1,2,3, Dianyan Chen1,3
1School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, 310024, Hangzhou, China.
npj antimicrobials and resistance
|April 12, 2025
概括
研究人员开发了针对UDP-N-乙烯基葡萄糖胺-无烯基酸盐N-乙烯基葡萄糖胺酸转移酶 (TarO) 的新型化合物,以对抗抗甲素耐药黄金葡萄球菌 (MRSA). 同类型18a证明了提高疗效,降低脂性和与抗生素的协同活性.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- UDP-N-乙烯基葡萄糖胺-undecaprenyl-酸盐N-乙烯基葡萄糖胺酸转移酶 (TarO) 涉及甲素耐药金黄色葡萄球菌 (MRSA) 的β-乳糖胺耐药性和毒性.
- 之前的TarO抑制剂面临着高脂性和酶抑制与β-乳酸敏感化之间的差相关性挑战.
研究的目的:
- 设计和合成具有改进性质的新型TarO抑制剂.
- 建立一种可靠的选方法,将酶活性与β-乳酸敏感性相关联.
- 确定一种用于打击MRSA的化合物.
主要方法:
- 设计和合成31种Tarocin A类似物.
- 基于发光的记者测定用于初步选.
- 测试beta-lactam协同作用,以评估化合物的疗效.
- 在体外和体内研究,以评估抗病毒性和协同作用.
主要成果:
- 在初步查和beta-lactam协同作用测试之间观察到强烈的相关性.
- 同类型18a表现出增强的TarO抑制和改善的水友性 (clogP = 3.2).
- 与塔罗辛A相比,同类型18a表现出优越的β-乳酸盐敏感化,抗生物膜和抗病毒活性.
- 在体内研究证实了18a与胺基的强有力的协同活性.
结论:
- 在MRSA感染中,TarO是一种可行的治疗点.
- 类似物18a代表了一个有前途的分子,用于开发新的抗MRSA策略.
- 改善的水友性和强大的协同作用使得18a成为进一步开发的有价值候选者.
更多相关视频
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
2.6K
07:50Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
1.4K
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
01:28Structure-Activity Relationships and Drug Design
450
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
450